1. Home
  2. ICCC vs AAME Comparison

ICCC vs AAME Comparison

Compare ICCC & AAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • AAME
  • Stock Information
  • Founded
  • ICCC 1982
  • AAME 1968
  • Country
  • ICCC United States
  • AAME United States
  • Employees
  • ICCC N/A
  • AAME N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • AAME Life Insurance
  • Sector
  • ICCC Health Care
  • AAME Finance
  • Exchange
  • ICCC Nasdaq
  • AAME Nasdaq
  • Market Cap
  • ICCC 35.4M
  • AAME 34.9M
  • IPO Year
  • ICCC 1987
  • AAME N/A
  • Fundamental
  • Price
  • ICCC $4.06
  • AAME $1.58
  • Analyst Decision
  • ICCC
  • AAME
  • Analyst Count
  • ICCC 0
  • AAME 0
  • Target Price
  • ICCC N/A
  • AAME N/A
  • AVG Volume (30 Days)
  • ICCC 7.2K
  • AAME 3.9K
  • Earning Date
  • ICCC 08-08-2024
  • AAME 08-06-2024
  • Dividend Yield
  • ICCC N/A
  • AAME 2.50%
  • EPS Growth
  • ICCC N/A
  • AAME N/A
  • EPS
  • ICCC N/A
  • AAME N/A
  • Revenue
  • ICCC $21,282,719.00
  • AAME $187,521,000.00
  • Revenue This Year
  • ICCC N/A
  • AAME N/A
  • Revenue Next Year
  • ICCC N/A
  • AAME N/A
  • P/E Ratio
  • ICCC N/A
  • AAME N/A
  • Revenue Growth
  • ICCC 32.89
  • AAME 2.74
  • 52 Week Low
  • ICCC $4.05
  • AAME $1.49
  • 52 Week High
  • ICCC $5.69
  • AAME $3.00
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 38.96
  • AAME 41.56
  • Support Level
  • ICCC $4.05
  • AAME $1.58
  • Resistance Level
  • ICCC $4.29
  • AAME $1.77
  • Average True Range (ATR)
  • ICCC 0.10
  • AAME 0.07
  • MACD
  • ICCC -0.01
  • AAME 0.00
  • Stochastic Oscillator
  • ICCC 4.00
  • AAME 22.32

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts. It also provides tailored business automobile insurance coverage, on a multi-year contract basis, to state governments and local municipalities, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance. It earns revenue from the collection of premiums and investment income.

Share on Social Networks: